A carregar...

Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.

The first double masked placebo controlled trial of interferon alfa-2a for the treatment of overt choroidal neovascular membranes is presented. A total of 43 consecutive patients were randomised to double masked treatment with either interferon alfa-2a, 3 million IU subcutaneously three times a week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Engler, C, Sander, B, Villumsen, J, Lund-Andersen, H
Formato: Artigo
Idioma:Inglês
Publicado em: 1994
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC504927/
https://ncbi.nlm.nih.gov/pubmed/7528534
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!